This is an issue we all need to address. It must be remembered that the pharmaceutical and chemical industries here are responsible for 40% of our exports and are big and good employers. As well as addressing the position of the companies, will Ms Scallon outline her views on whether drugs which have been tested on embryonic stem cells should be permitted for use here no matter how efficacious?